
Lee Zou | Duke Department of Pharmacology and Cancer Biology
Lee. Zou. George Barth Geller Distinguished Professor. Professor of Pharmacology and Cancer Biology. Chair, Department of Pharmacology and Cancer Biology. Member of the Duke Cancer Institute. Primary Faculty. [email protected].
Zou Lab | Duke Department of Pharmacology and Cancer Biology
The Zou laboratory is particularly interested in understanding how the checkpoint detects DNA damage and genomic instability, and how the checkpoint can be targeted in cancer therapy.
Lee Zou Named New Chair of Department of Pharmacology and …
Oct 3, 2022 · Lee Zou, PhD, has been named the new chair of the Department of Pharmacology and Cancer Biology. He will begin his new role on Feb. 1, 2023. Colin Duckett, PhD, Vice Dean for Basic Science and Professor of Pharmacology and Cancer Biology, has served as interim chair of the department since September 2020.
Lee Zou | Harvard Division of Medical Sciences - Harvard University
Mutations impairing the functions of this signaling pathway associate with cancers and cancer predisposition syndromes (e.g. p53, Brca1, ATM, Chk2, and Nbs1).
Lee Zou - Google Scholar
Lee Zou. Duke University. Verified email at duke.edu. Articles Cited by Public access. Title. Sort. Sort by citations Sort by year Sort by title. Cited by. Cited by. Year; Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. L Zou, SJ …
Lee Zou, PhD, MGH Research Scholar Profile - Massachusetts General Hospital
The laboratory of MGH Research Scholar Lee Zou, PhD, is investigating the genetic and epigenetic changes in the human genome that contribute to the development of cancer. Cancer is a complex disease driven by genetic and epigenetic alterations in the genome.
Lee Zou | George Barth Geller Distinguished Professor | Duke …
2018-2028 American Society for Pharmacology and Experimental Therapeutics. 2023-2026 Massachusetts General Hospital. 2023-2025 Lung Cancer Research Foundation.
Lee Zou, PhD and Raul Mostoslavsky, MD, PhD Named …
Lee Zou, the Poitras Family Chair in Cancer Research at Mass General and Professor of Pathology at Harvard Medical School, is a renowned authority on DNA damage repair, the role of ATR signaling in cancer cell replication stress, and pathways targeted by inhibitors of DNA homologous recombination.
Pharmacology and Cancer Biology: Writing the Next Chapter
Dec 5, 2023 · Lee Zou, PhD, joined the Duke faculty in March 2023 as chair of the Department of Pharmacology and Cancer Biology in part because of the very collegial environment he found in Durham. He was previously professor of pathology at Harvard Medical School and scientific co-director of Massachusetts General Cancer Center.
Lee Zou - Duke University School of Medicine
Lee. Zou. George Barth Geller Distinguished Professor. Professor of Pharmacology and Cancer Biology. Chair, Department of Pharmacology and Cancer Biology. Member of the Duke Cancer Institute. University Program in Genetics and Genomics. [email protected].